Distributed Bio: Distributed Bio Partners With Mediar Therapeutics, Inc.
Distributed Bio, a global leader in computational optimization of fully human monoclonal antibody libraries, is pleased to announce a comprehensive research partnership with Mediar Therapeutics, a preclinical stage biotechnology company...Read More
Read full article »
Distributed Bio develops a San Francisco-based cloud computational platform that provides antibody repertoire analysis and therapeutic discovery solutions.
Read more